Adverse events98

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 40 of 98

Type	Event	Organ system	Group	Affected	At risk
serious	Constipation	Gastrointestinal disorders	Placebo	0	163
serious	Constipation	Gastrointestinal disorders	Relamorelin 10 μg	1	163
serious	Gastrointestinal haemorrhage	Gastrointestinal disorders	Placebo	0	163
serious	Gastrointestinal haemorrhage	Gastrointestinal disorders	Relamorelin 10 μg	1	163
serious	Impaired gastric emptying	Gastrointestinal disorders	Placebo	0	163
serious	Impaired gastric emptying	Gastrointestinal disorders	Relamorelin 10 μg	1	163
serious	Diabetic gastroparesis	Gastrointestinal disorders	Placebo	1	163
serious	Diabetic gastroparesis	Gastrointestinal disorders	Relamorelin 10 μg	0	163
serious	Pancreatitis	Gastrointestinal disorders	Placebo	1	163
serious	Pancreatitis	Gastrointestinal disorders	Relamorelin 10 μg	0	163
serious	Pneumonia	Infections and infestations	Placebo	3	163
serious	Pneumonia	Infections and infestations	Relamorelin 10 μg	2	163
serious	Diverticulitis	Infections and infestations	Placebo	0	163
serious	Diverticulitis	Infections and infestations	Relamorelin 10 μg	2	163
serious	Urinary tract infection	Infections and infestations	Placebo	2	163
serious	Urinary tract infection	Infections and infestations	Relamorelin 10 μg	1	163
serious	Acute sinusitis	Infections and infestations	Placebo	0	163
serious	Acute sinusitis	Infections and infestations	Relamorelin 10 μg	1	163
serious	Sepsis	Infections and infestations	Placebo	2	163
serious	Sepsis	Infections and infestations	Relamorelin 10 μg	0	163

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03285308/events?page=2